Justin R. Ortiz
University of Maryland, Baltimore
H-index: 56
North America-United States
Top articles of Justin R. Ortiz
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Safety and Immunogenicity of a Delayed Heterologous Avian Influenza A (H7N9) Vaccine Boost Following Different Priming Regimens: A Randomized Clinical Trial | The Journal of infectious diseases | Hana M El Sahly Inci Yildirim Sharon E Frey Patricia Winokur Lisa A Jackson | 2024/2/15 |
Immunization Advice in ATS Clinical Guidance Documents: A Systematic Review | AC Gilmore KC Wilson J Corn AW Jones TV Hartert | 2024/5 | |
Relative Effectiveness of the MF59®‐Adjuvanted Influenza Vaccine Versus High‐Dose and Non‐Adjuvanted Influenza Vaccines in Preventing Cardiorespiratory Hospitalizations During … | Influenza and Other Respiratory Viruses | Mahrukh Imran Joan Puig‐Barbera Justin R Ortiz Lorena Lopez‐Gonzalez Alex Dean | 2024/4 |
Safety and immunogenicity of influenza A/H5N8 virus vaccine in healthy adults: durability and cross-reactivity of antibody responses | Clinical Infectious Diseases | Kathleen M Neuzil Evan J Anderson Robert W Frenck Sharon E Frey Emmanuel B Walter | 2023/1/5 |
Age differences in comorbidities, presenting symptoms, and outcomes of influenza illness requiring hospitalization: a worldwide perspective from the global influenza hospital … | Open Forum Infectious Diseases | Melissa K Andrew Henrique Pott Lisa Staadegaard John Paget Sandra S Chaves | 2023/6 |
Global, regional and national estimates of influenza-attributable ischemic heart disease mortality | EClinicalMedicine | Sandra S Chaves Joshua Nealon Katrin G Burkart Daniel Modin Tor Biering-Sørensen | 2023/1/1 |
Optimizing next-generation RSV prevention in Mali: a cost-effectiveness analysis of pediatric vaccination, maternal vaccination, and extended half-life monoclonal antibody … | PLOS Global Public Health | Rachel S Laufer Ranju Baral Andrea G Buchwald James D Campbell Flanon Coulibaly | 2023/5/5 |
Report of the WHO technical consultation on the evaluation of respiratory syncytial virus prevention cost effectiveness in low-and middle-income countries, April 7–8, 2022 | Vaccine | Meagan C Fitzpatrick Rachel S Laufer Ranju Baral Amanda J Driscoll Daniel R Feikin | 2023/11/22 |
Leukotriene Modifying Agent Prophylaxis to Prevent Excess Morbidity and Mortality From Influenza: Two Observational Cohort Studies Using Medicaid and Department of Defense … | BM Snyder CA Riddell T Gebretsadik T Ding WD Dupont | 2023/5 | |
Value profile for respiratory syncytial virus vaccines and monoclonal antibodies | Vaccine | Jessica A Fleming Ranju Baral Deborah Higgins Sadaf Khan Sonali Kochar | 2023/11/3 |
Rates and Risk Factors for RSV Infection Among Term Healthy Infants in a Population-based US Cohort | F Cacho T Gebretsadik L Anderson C Rosas-Salazar JR Ortiz | 2023/5 | |
A Multicenter, Controlled Human Infection Study of Influenza A (H1N1) pdm09 in Healthy Adults | The Journal of Infectious Diseases | Justin R Ortiz David I Bernstein Daniel F Hoft Christopher W Woods Micah T McClain | 2023/8/1 |
Model-estimated impacts of pediatric respiratory syncytial virus prevention programs in Mali on asthma prevalence | Journal of Allergy and Clinical Immunology: Global | Justin R Ortiz Rachel S Laufer Steven M Brunwasser Flanon Coulibaly Fatoumata Diallo | 2023/5/1 |
Relative Effectiveness of the Cell-Based Quadrivalent Influenza Vaccine in Preventing Cardiorespiratory Hospitalizations in Adults Aged 18–64 Years During the 2019–2020 US … | Open Forum Infectious Diseases | Mahrukh Imran Juan Puig-Barbera Justin R Ortiz Lorena Lopez-Gonzalez Alex Dean | 2023/7 |
Relative effectiveness of MF59 adjuvanted trivalent influenza vaccine vs nonadjuvanted vaccines during the 2019–2020 influenza season | Open forum infectious diseases | Mahrukh Imran Joan Puig-Barbera Justin R Ortiz Lauren Fischer Dan O’Brien | 2022/5/1 |
Review of analyses estimating relative vaccine effectiveness of cell-based quadrivalent influenza vaccine in three consecutive US influenza seasons | Vaccines | Constantina Boikos Ian McGovern Deborah Molrine Justin R Ortiz Joan Puig-Barberà | 2022/6/3 |
Validation of International Classification of Diseases criteria to identify severe influenza hospitalizations | Journal of the American Academy of Dermatology | Youkyung Sophie Roh Melika Marani Una Choi Nishadh Sutaria Varsha Parthasarathy | 2022/8/1 |
Efficacy and Safety of NVX-CoV2373 in Adults in the United States and Mexico | New England Journal of Medicine | Lisa M Dunkle Karen L Kotloff Cynthia L Gay Germán Áñez Jeffrey M Adelglass | 2022/2/10 |
Need for improved global measurement of early childhood respiratory syncytial virus disease | The Lancet | Tina V Hartert Justin R Ortiz | 2022/5/28 |
486. A/California/07/2009-pdm-like (H1N1) Influenza Virus Controlled Human Infection Model (CHIM) Activates Various Immune Cells Despite Induction of Mild Symptomatology | Open Forum Infectious Diseases | Franklin R Toapanta Paula Bernal Jingping Hu Paul C Roberts Catherine J Luke | 2022/12/1 |
Co-Authors
